Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued

Go back to Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued
(NASDAQ: IONS) Delayed: 40.15 -0.27 (0.67%)
Previous Close $40.42    52 Week High $62.68 
Open $41.38    52 Week Low $19.59 
Day High $41.53    P/E N/A 
Day Low $39.33    EPS $0.00 
Volume 4,102,749       

UNIQURE (NASDAQ: QURE) Delayed: 23.03 -0.84 (3.52%)
Previous Close $23.87    52 Week High $22.79 
Open $24.10    52 Week Low $6.63 
Day High $24.22    P/E N/A 
Day Low $21.51    EPS $0.00 
Volume 2,661,144       

(NASDAQ: WVE) Delayed: 3.62 +0.04 (1.12%)
Previous Close $3.58    52 Week High $38.50 
Open $3.70    52 Week Low $8.95 
Day High $3.78    P/E N/A 
Day Low $3.56    EPS $0.00 
Volume 2,745,330